TrialCancer2025

A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX.

Eduardo Rodríguez-Arbolí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.